Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00740
|
|||||
| Drug Name |
Temanogrel
|
|||||
| Synonyms |
5-HT 2a inverse agonist (arterial thrombosis), Arena Pharmaceutical; APD-791; Temanogrel hydrochloride
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
![]() |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C24H28N4O4
|
|||||
| Canonical SMILES |
CN1C(=CC=N1)C2=C(C=CC(=C2)NC(=O)C3=CC(=CC=C3)OC)OCCN4CCOCC4
|
|||||
| InChI |
InChI=1S/C24H28N4O4/c1-27-22(8-9-25-27)21-17-19(26-24(29)18-4-3-5-20(16-18)30-2)6-7-23(21)32-15-12-28-10-13-31-14-11-28/h3-9,16-17H,10-15H2,1-2H3,(H,26,29)
|
|||||
| InChIKey |
ZEOQUKRCASTCFR-UHFFFAOYSA-N
|
|||||
| Pharmaceutical Properties | Molecular Weight | 436.5 | Topological Polar Surface Area | 77.8 | ||
| Heavy Atom Count | 32 | Rotatable Bond Count | 8 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
2.3
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
